Zacks Releases Four Powerful ''Buy'' Stocks: Osiris Therapeutics, Bancolombia, JAKKS Pacific and ReneSola Limited - Press Releases

For Immediate Release

Chicago, IL – November 11, 2010 – Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.

The four highlighted picks are: Osiris Therapeutics, Inc. (OSIR), Bancolombia (CIB), JAKKS Pacific, Inc. (JAKK) and ReneSola Limited (SOL).

Today, Zacks informs investors of its ''Buy'' stock recommendations. Four daily picks are offered free at http://at.zacks.com/?id=5607.

Zacks #1 Rank Stocks have nearly tripled the S&P 500 since 1988, producing an average annual return of +28%. Performance has been notable even during volatile and down times. For example, during the last bear market, 2000-2002, the market tumbled -37.6% – but Zacks #1 Rank stocks gained +43.8%.

Here is a summary of today's selected stocks that are now highly rated by Zacks:

Aggressive Growth – Osiris Therapeutics, Inc. (OSIR)
Osiris Therapeutics, Inc. has analysts buzzing over the prospects for the next couple of years. Estimates are surging after the third consecutive earnings surprise.

Zacks Guide to Aggressive Growth Investing (free!): http://at.zacks.com/?id=4309

Growth & Income – Bancolombia (CIB)
With BRIC countries all the rage these days, investors often overlook other strong emerging markets. Through free market reforms and a stable political climate, Colombia has been one of Latin America's strongest economies over the last several years. Bancolombia is Colombia's largest bank and stands to benefit from continued economic growth. The company recently reported a strong third quarter marked by solid loan demand and improving credit trends.

Zacks Guide to Growth & Income Investing (free!): http://at.zacks.com/?id=4310

Momentum – JAKKS Pacific, Inc. (JAKK)
JAKKS Pacific, Inc. recently jumped to a new multi-year high at $19.96 after reporting a 15% Q3 earnings surprise in late October. With a compelling valuation and rising estimates, this Zacks #1 rank stock provides plenty of upward momentum for investors to play with.

Zacks Guide to Momentum Investing (free!): http://at.zacks.com/?id=4311

Value – ReneSola Limited (SOL)
Solar companies are suddenly hot again but even with a big surge in share prices many of them are still dirt cheap. ReneSola Limited is trading with a forward P/E of just 7. With big earnings growth, it also is a rare value and growth stock.

Zacks Guide to Value Investing (free!): http://at.zacks.com/?id=4312

How to Regularly Access Top Zacks Rank Picks Free: http://at.zacks.com/?id=7156

Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. in Mathematics from M.I.T. found that "earnings estimate revisions are the most powerful force impacting stock prices." Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.

Today, Zacks releases stock recommendations by offering four daily picks free to those who register at http://at.zacks.com/?id=7157

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they're applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.

More Free Stock Picks

Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription at http://at.zacks.com/?id=5642

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Zacks.com

Aggressive Growth Stocks:
Contact: Bill Wilton
Phone: 312-265-9277

or

Growth & Income Stocks:
Contact: Rob Plaza
Phone: 312-265-9442

or

Momentum Stocks:
Contact: Michael Vodicka
Phone: 312-265-9226

or

Value Stocks:
Contact: Tracey Ryniec
Phone: 312-265-9232

Email: pr@zacks.com
Visit: www.zacks.com

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

 

 
BANCOLOMBIA-ADR (CIB): Free Stock Analysis Report
 
JAKKS PACIFIC (JAKK): Free Stock Analysis Report
 
OSIRIS THERAPTC (OSIR): Free Stock Analysis Report
 
RENESOLA LT-ADR (SOL): Free Stock Analysis Report
 
Zacks Investment Research